Published in Am J Pathol on January 01, 1995
The immune system and cardiac repair. Pharmacol Res (2008) 3.42
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med (2014) 3.23
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol (2007) 2.27
Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res (2011) 2.26
Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal (2006) 2.22
Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol (2003) 2.22
Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia (2009) 2.18
Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem (2003) 2.12
Host responses in tissue repair and fibrosis. Annu Rev Pathol (2012) 2.10
Fibroblast heterogeneity in the cancer wound. J Exp Med (2014) 2.09
Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc (2006) 1.98
Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One (2010) 1.95
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol (1995) 1.95
Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am J Pathol (2005) 1.93
Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med (2008) 1.93
Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol (2010) 1.83
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther (2005) 1.81
Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest (2013) 1.81
Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol (2010) 1.75
Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol (2003) 1.71
Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol (2006) 1.54
Is liver fibrosis reversible? Gut (2000) 1.52
Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol (1998) 1.51
Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol (2013) 1.51
Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol (1996) 1.49
The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr (2012) 1.46
Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat. Br J Pharmacol (2009) 1.45
Apoptosis in the initiation, modulation and termination of the corneal wound healing response. Exp Eye Res (2007) 1.45
Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One (2012) 1.41
Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J (2009) 1.41
Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci (2012) 1.40
Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol (2004) 1.39
Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J (2008) 1.37
Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol (2013) 1.36
Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype. J Biol Chem (2009) 1.34
Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol (1996) 1.33
Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol (1998) 1.30
The spatio-temporal dynamics of ligament healing. Wound Repair Regen (2009) 1.27
Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol (2013) 1.25
Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol (2005) 1.23
Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther (2006) 1.22
Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol (2014) 1.22
Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. Proc Natl Acad Sci U S A (2013) 1.20
Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell (2007) 1.20
Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol (2009) 1.20
Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am J Respir Cell Mol Biol (2007) 1.20
Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs (2011) 1.19
PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. Am J Physiol Lung Cell Mol Physiol (2007) 1.19
Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate-induced acute renal failure in rats. Virchows Arch (2004) 1.18
TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am J Respir Cell Mol Biol (2005) 1.17
Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis (1997) 1.14
Common threads in cardiac fibrosis, infarct scar formation, and wound healing. Fibrogenesis Tissue Repair (2012) 1.12
Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg (2000) 1.12
Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem (2011) 1.10
Mechanoregulation of the Myofibroblast in Wound Contraction, Scarring, and Fibrosis: Opportunities for New Therapeutic Intervention. Adv Wound Care (New Rochelle) (2013) 1.10
Morphological aspects of apoptosis in heart diseases. J Cell Mol Med (2006) 1.09
Cardiac fibroblast in development and wound healing. J Mol Cell Cardiol (2014) 1.05
Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair (2013) 1.05
Effects of exercise training on cardiac function and myocardial remodeling in post myocardial infarction rats. J Mol Cell Cardiol (2007) 1.04
The fibrosis-cell death axis in heart failure. Heart Fail Rev (2016) 1.04
Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb Haemost (2008) 1.03
Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol (1997) 1.03
VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res (2002) 1.03
Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res (2011) 1.02
Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. Proc Natl Acad Sci U S A (2007) 1.01
FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging (2014) 1.00
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases. J Pharmacol Exp Ther (2007) 1.00
In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol (1996) 1.00
Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis. Int J Biochem Cell Biol (2011) 0.99
Epithelial-mesenchymal interactions in pulmonary fibrosis. Semin Respir Crit Care Med (2006) 0.99
The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization. Am J Pathol (1999) 0.99
Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med (2014) 0.99
Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol (2001) 0.99
The wound healing, chronic fibrosis, and cancer progression triad. Physiol Genomics (2014) 0.99
Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care (2012) 0.98
Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells. PLoS One (2014) 0.98
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol (2012) 0.98
Cellular and Molecular Characteristics of Scarless versus Fibrotic Wound Healing. Dermatol Res Pract (2010) 0.97
In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS One (2011) 0.96
Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol (2009) 0.95
Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol (1996) 0.95
The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair (2012) 0.95
In vitro wounding: effects of hypoxia and transforming growth factor beta1 on proliferation, migration and myofibroblastic differentiation in an endothelial cell-fibroblast co-culture model. J Mol Histol (2007) 0.94
Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol (1997) 0.94
Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. J Dent Res (2010) 0.93
Mechanical forces induce scar remodeling. Study in non-pressure-treated versus pressure-treated hypertrophic scars. Am J Pathol (1999) 0.93
Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J (2013) 0.93
X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis. Am J Respir Cell Mol Biol (2013) 0.92
Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats. Am J Pathol (2004) 0.92
Reversal of myofibroblasts by amniotic membrane stromal extract. J Cell Physiol (2008) 0.92
What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine. Br J Sports Med (2004) 0.92
Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts. Cell Death Dis (2013) 0.92
Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging. J Nucl Cardiol (2010) 0.90
Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol (2000) 0.90
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy. Treat Respir Med (2006) 0.90
Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol (1997) 0.90
The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases. Clin Transl Med (2015) 0.90
Apoptotic cell: linkage of inflammation and wound healing. Front Pharmacol (2014) 0.90
Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc Res (2013) 0.89
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 17.69
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Bcl-2 and the regulation of programmed cell death. J Cell Biol (1994) 7.88
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell (1993) 7.16
A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol (1986) 6.83
Apoptosis. Its significance in cancer and cancer therapy. Cancer (1994) 6.71
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A (1991) 5.50
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia (1971) 5.14
Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci U S A (1983) 4.81
Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest (1990) 4.67
Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol (1994) 4.60
Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03
Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol (1988) 3.64
Molecular regulation of apoptosis: genetic controls on cell death. Cell (1993) 3.57
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem (1993) 3.41
Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg (1989) 2.96
Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci U S A (1981) 2.94
Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev (1993) 2.76
Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu (1982) 2.54
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J (1993) 2.50
Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol (1994) 2.44
Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci (1992) 2.40
Localization of gold in biological tissue. A photochemical method for light and electronmicroscopy. Histochemistry (1981) 2.24
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol (1993) 2.07
Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol (1989) 1.98
Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci (1992) 1.90
Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol (1991) 1.88
Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci (1994) 1.85
Mechanisms of immune lysis. III. Characterization of the nature and kinetics of the cytotoxic T lymphocyte-induced nuclear lesion in the target. J Immunol (1982) 1.80
In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med (1988) 1.64
Regulation of fibroplasia in cutaneous wound repair. Am J Med Sci (1993) 1.60
Death-defying acts: a meeting review on apoptosis. Genes Dev (1993) 1.49
One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest (1993) 1.42
Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int J Radiat Biol Relat Stud Phys Chem Med (1988) 1.38
The apoptosis endonucleases: cleaning up after cell death? Trends Cell Biol (1994) 1.35
Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest (1993) 1.34
Death of cells by apoptosis following attachment of specifically allergized lymphocytes in vitro. Aust J Exp Biol Med Sci (1977) 1.30
Scarless fetal healing. Therapeutic implications. Ann Surg (1992) 1.25
Hypertrophic scars and keloids: a review and new concept concerning their origin. Scan Electron Microsc (1982) 1.22
Tumor necrosis factor and wound healing. Ann Surg (1990) 1.19
Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest (1994) 1.16
Apoptosis and signal transduction: clues to a molecular mechanism. Curr Opin Cell Biol (1993) 1.16
Biochemical evidence for programmed cell death in rabbit uterine epithelium. Am J Pathol (1989) 1.16
Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology (1993) 1.13
Histologic basis of keloid and hypertrophic scar differentiation. Clinicopathologic correlation. Arch Pathol (1966) 1.09
Apoptosis: the physiologic pathway of cell death. Hosp Pract (Off Ed) (1993) 1.02
Growth factors and cutaneous wound repair. Prog Growth Factor Res (1992) 1.01
In situ nick translation of human and mouse chromosomes detected with a biotinylated nucleotide. Exp Cell Res (1985) 0.99
Clusterin: an enigmatic protein recruited by diverse stimuli. J Lab Clin Med (1993) 0.92
Inhibition of myofibroblasts by skin grafts. Plast Reconstr Surg (1979) 0.91
Multiple pathways to apoptosis. Cell Biol Int (1993) 0.89
Transforming growth factor-beta stimulates endometrial stromal apoptosis in vitro. Endocrinology (1994) 0.86
In situ nick translation of metaphase chromosomes with biotin-labeled d-UTP. Hum Genet (1985) 0.86
Commitment to cell death is signaled by the appearance of a terminin protein of 30 kDa. Exp Cell Res (1994) 0.85
Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol (1993) 8.36
A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol (1986) 6.83
Granulation tissue as a contractile organ. A study of structure and function. J Exp Med (1972) 5.42
Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia (1971) 5.14
Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest (1990) 4.67
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell (2001) 4.25
Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res (1999) 3.78
The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65
Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol (1973) 3.36
Contraction of granulation tissue in vitro: similarity to smooth muscle. Science (1971) 3.29
Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest (1990) 3.15
Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol (2001) 3.07
Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol (1981) 2.94
Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci U S A (1981) 2.94
Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol (1992) 2.72
Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol (1994) 2.44
Dupuytren's contracture: fibroblast contraction? An ultrastructural study. Am J Pathol (1972) 2.31
Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest (1989) 2.30
Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem (1989) 2.23
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16
Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest (1984) 2.15
"Contractile interstitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol (1974) 2.11
Actin and tubulin co-cap with surface immunoglobulins in mouse B lymphocytes. Nature (1977) 2.10
Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer (1988) 2.01
Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest (1984) 1.95
The role of cytoskeletal and cytocontractile elements in pathologic processes. Am J Pathol (1983) 1.91
The myofibroblast: a quarter century after its discovery. Am J Surg Pathol (1998) 1.82
Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch (1994) 1.79
Phalloidin-induced hyperplasia of actin filaments in rat hepatocytes. Lab Invest (1975) 1.78
Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci (2001) 1.75
Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med (1989) 1.70
Myofibroblasts in human granulation tissue. Hum Pathol (1974) 1.68
Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. Am J Respir Crit Care Med (1995) 1.67
Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest (1996) 1.65
Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun (1989) 1.65
Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res (1992) 1.64
Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol (1991) 1.62
Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies. Cancer (1975) 1.62
Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg (1994) 1.58
Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis (1988) 1.57
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56
Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. Exp Cell Res (1982) 1.52
Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing. J Cell Biol (1978) 1.52
Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab Invest (1989) 1.50
The contractile fibroblast. Its relevance in plastic surgery. Plast Reconstr Surg (1973) 1.46
Intranuclear injection of anti-actin antibodies into Xenopus oocytes blocks chromosome condensation. Nature (1979) 1.45
Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol (1993) 1.44
Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol (1997) 1.44
Collagen and myofibroblasts of granulation tissue. A chemical, ultrastructural and immunologic study. Virchows Arch B Cell Pathol (1976) 1.43
Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation (1996) 1.43
Cytoskeletal features of rat aortic cells during development. An electron microscopic, immunohistochemical, and biochemical study. Circ Res (1985) 1.43
Polarized distribution of actin isoforms in gastric parietal cells. Mol Biol Cell (1995) 1.41
An actin-destabilizing factor is present in human plasma. Experientia (1979) 1.41
Fibroblasts of granulation tissue: immunofluorescent staining with antismooth muscle serum. Proc Soc Exp Biol Med (1971) 1.41
Cytoplasmic contractile apparatus in aortic endothelial cells of hypertensive rats. Lab Invest (1975) 1.41
A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology (1999) 1.40
Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. Differentiation (1988) 1.39
Colonic pericryptal fibroblasts. Differentiation pattern in embryogenesis and phenotypic modulation in epithelial proliferative lesions. Virchows Arch A Pathol Anat Histopathol (1989) 1.39
Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol (1986) 1.39
Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol (1995) 1.39
Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol (1990) 1.36
Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Invest (1982) 1.34
Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab Invest (1986) 1.33
Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol (1997) 1.32
Increase of contractile proteins in human cancer cells. Lancet (1975) 1.32
Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis (1989) 1.32
Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 1.31
Interferon-gamma inhibits experimental renal fibrosis. Kidney Int (1999) 1.30
Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology (1992) 1.30
Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation (2001) 1.28
Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res (1998) 1.27
Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest (1991) 1.25
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension (1998) 1.25
Actin microfilaments, cell shape, and secretory processes in isolated rat hepatocytes. Effect of phalloidin and cytochalasin D. J Cell Biol (1979) 1.25
The area of attachment of cytotoxic T lymphocytes to their target cells shows high motility and polarization of actin, but not myosin. J Immunol (1982) 1.23
Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol (1988) 1.22
Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochem Cytochem (1988) 1.22
Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation. Circ Res (1999) 1.22
alpha-Actinin attached to membranes of secretory vesicles. Nature (1977) 1.20
The myofibroblast: a key cell for wound healing and fibrocontractive diseases. Prog Clin Biol Res (1981) 1.20
Lymphocyte alpha-actinin. Relationship to cell membrane and co-capping with surface receptors. J Cell Biol (1980) 1.20
Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am J Pathol (1987) 1.19
Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol (1986) 1.19
Human plasma actin-depolymerizing factor. Purification, biological activity and localization in leukocytes and platelets. Eur J Biochem (1985) 1.19
Actin-isoform pattern as a marker of normal or pathological smooth-muscle and fibroblastic tissues. Differentiation (1987) 1.19
Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton (1988) 1.18
Organization of actin cytoskeleton in normal and regenerating arterial endothelial cells. Proc Natl Acad Sci U S A (1983) 1.18
Contractile proteins in human cancer cells. Immunofluorescent and electron microscopic study. Am J Pathol (1976) 1.18
The intermediate filament proteins of rabbit normal epidermal Merkel cells are cytokeratins. J Invest Dermatol (1984) 1.17
Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors. Am J Pathol (1983) 1.16
Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol (1997) 1.16
Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am J Pathol (1987) 1.15
Morphologic and functional changes of the aortic intima during experimental hypertension. Am J Pathol (1979) 1.15
Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J Physiol (2009) 1.13
Heparin induces alpha-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab Invest (1992) 1.12
Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest (1997) 1.12